CoChat

Exosomal PD-L1 induces osteogenic differentiation and promotes fracture healing by acting as an immunosuppressant

Open access
Lin, Ze, Xiong, Yuan, Meng, Weilin, Hu, Yiqiang, Chen, Lili, Chen, Lang, Xue, Hang, Panayi, Adriana C., Zhou, Wu, Sun, Yun, Cao, Faqi, Liu, Guodong, Hu, Liangcong, Yan, Chenchen, Xie, Xudong, Lin, Chuanchuan, Cai, Kaiyong, Feng, Qian, Mi, Bobin, Liu, Guohui · 2022 · Bioactive Materials
Cited by 73

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

A moderate inflammatory response at the early stages of fracture healing is necessary for callus formation. Over-active and continuous inflammation, however, impairs fracture healing and leads to excessive tissue damage. Adequate fracture healing could be promoted through suppression of local over-active immune cells in the fracture site. In the present study, we achieved an enriched concentration of PD-L1 from exosomes (Exos) of a genetically engineered Human Umbilical Vein Endothelial Cell (HUVECs), and demonstrated that exosomes overexpressing PD-L1 specifically bind to PD-1 on the T cell surface, suppressing the activation of T cells. Furthermore, exosomal PD-L1 induced Mesenchymal Stem Cells (MSCs) towards osteogenic differentiation when pre-cultured with T cells. Moreover, embedding of Exos into an injectable hydrogel allowed Exos delivery to the surrounding microenvironment in a time-released manner. Additionally, exosomal PD-L1, embedded in a hydrogel, markedly promoted callus formation and fracture healing in a murine model at the early over-active inflammation phase. Importantly, our results suggested that activation of T cells in the peripheral lymphatic tissues was inhibited after local administration of PD-L1-enriched Exos to the fracture sites, while T cells in distant immune organs such as the spleen were not affected. In summary, this study provides the first example of using PD-L1-enriched Exos for bone fracture repair, and highlights the potential of Hydrogel@Exos systems for bone fracture therapy through immune inhibitory effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bioactmat.2021.10.042

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 73

Metadata

Authors
Lin, Z., Xiong, Y., Meng, W., Hu, Y., Chen, L., Chen, L., Xue, H., Panayi, A. C., Zhou, W., Sun, Y., Cao, F., Liu, G., Hu, L., Yan, C., Xie, X., Lin, C., Cai, K., Feng, Q., Mi, B., & Liu, G.
Venue
Bioactive Materials
Publisher
Elsevier BV
Published
2022-07
Volume
13
Pages
300-311
ISSN
  • 2097-1192 (ISSN-L)
  • 2452-199X
OpenAlex
W3210884827
Cited by
73
References
4
FWCI
3.29
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exosomal PD-L1 induces osteogenic differentiation and promotes fracture healing by acting as an immunosuppressant. https://app.cochat.ai/papers/10.1016/j.bioactmat.2021.10.042
The paper
Lin, Z., Xiong, Y., Meng, W., Hu, Y., Chen, L., Chen, L., Xue, H., Panayi, A. C., Zhou, W., Sun, Y., Cao, F., Liu, G., Hu, L., Yan, C., Xie, X., Lin, C., Cai, K., Feng, Q., Mi, B., & Liu, G. (2022). Exosomal PD-L1 induces osteogenic differentiation and promotes fracture healing by acting as an immunosuppressant. Bioactive Materials. https://doi.org/10.1016/j.bioactmat.2021.10.042

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.